PORTLAND, Ore. (December 12, 2023) — Reperio Health, the only provider of at-home and onsite comprehensive health screenings with instant results, announced today that the company has exceeded its year-over-year growth by over 500% — a massive win for the Portland-based digital health startup given the tough year faced by the healthcare industry-at-large in 2023.
In addition to company growth, Reperio ends the year with more than two dozen new clients that represent over 40,000 contracted screenings, plus major investments in innovative product updates to improve access to biometric health screenings data.
Some company highlights for the year include:
- Client wins across multiple industry sectors. Innovative wellness solutions for hybrid workforces are top of mind for many executives across multiple sectors, as made clear by the variety of industries represented by Reperio’s new clients and partners who signed in 2023. Some notable clients include Portland-based employer Bob’s Red Mill, and global health and wellbeing company Vitality Global. Reperio’s partnership with AccessCare Health even took screenings internationally, with thousands of screenings contracted by Workday in the U.K. and Ireland. The second biggest industry represented by Reperio clients in 2023 was within the payor space, including a partnership with a large state-based plan set to begin in January 2024.
- Product updates focused on the consumer experience. Given the uptick in screenings in 2023, Reperio focused on innovative product updates that would continue to prioritize the consumer experience. The team released a feature that allows users to transmit their biometric health data to their care team at their own discretion. Additionally, the company’s 24/7 live customer experience support team has consistently maintained close to 100% satisfaction ratings throughout the year.
- In-person event demos drive product-marketing alignment. Reperio was showcased at many in-person events throughout the year, including SHRM’s Annual Conference, HLTH, and Benefits at Work. With more than 450 live screenings completed at these shows for conference attendees, the company used real-time feedback to confirm product-market alignment, including an upcoming A1C offering.
- Support for chronic- and long-term disease management. More than 38 million Americans have diabetes, and that highlights the need for digital health solutions like Reperio’s to support care gaps for chronic- and long-term diseases. As mentioned above, Reperio beta-tested an A1C screening offering at the SHRM trade show with much success, which now drives plans for a more extensive A1C product rollout in 2024 to all clients and prospects.
Other big company wins include Reperio’s recognition as a Rising Star winner for the Employer Subsidized Wellness category at the Digital Health Hub Foundation Awards, the hiring of seasoned healthcare executive Naomi Levinthal as the company’s first Chief Growth Officer, a mention as a Top 10 Medical Device Startup by GreyB, and a partnership with Employee Benefits News on a successful webinar on biometric screenings for the modern workforce.
Said Travis Rush, CEO and co-founder of Reperio, “We are more focused than ever on the opportunity to improve the health of communities by giving them access to their biometric health data. We continue our commitment to modernize the costly and inaccessible screening processes deployed today and will invest in whatever we can do to support preventive and equitable care that helps close gaps and improve population health for all our clients and the communities they serve.”